Found 2,353 articles
Novo Nordisk & ATLATL announce winners in their joint program EntreStar
Novo Nordisk Research Centre China and ATLATL jointly announce the winners of EntreStar program.
The Gustave Roussy Institute Integrates Synapse Platform to Ensure Complex Prescription Safety
France's Gustave Roussy Institute, Europe's leading cancer center and ranked third in the world according to Newsweek Magazine, has chosen to partner with Synapse Medicine, a leader in clinical pharmacy and medication reconciliation.
Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies
Florida Cancer Specialists & Research Institute, LLC takes exception to a recent study published in the New England Journal of Medicine suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought.
Distinguished Cancer and Stem Cell Biologist Ulrich Steidl, M.D., Ph.D., Appointed Chair of Cell Biology at Albert Einstein College of Medicine
Ulrich Steidl, M.D., Ph.D., an internationally recognized leader in cancer and stem cell biology, has been named the chair of the department of cell biology at Albert Einstein College of Medicine.
City of Hope Study Finds Medicare Advantage May Put Complex Cancer Surgery Patients at a Disadvantage
An analysis by researchers at City of Hope found that cancer patients with privatized, cost-saving Medicare Advantage were more likely than those with traditional Medicare to go to hospitals with physicians less experienced at performing complicated surgeries, and that they were more likely to die within the first 30 days after the removal of their stomach, pancreas or liver.
Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow
Berkeley Lights, Inc., a leader in digital cell biology, announced the launch of the Opto® Memory B Discovery Rabbit workflow, expanding the diversity of antibodies customers can discover on the Beacon® platform.
New research out of McMaster University found a recently abandoned Bayer compound halted the growth of an aggressive form of pediatric medulloblastoma in mouse models.
Feinstein Institutes lupus researchers recognized with top honors
In recognition of their ongoing research and leadership in rheumatology, The Feinstein Institutes for Medical Research’s Betty Diamond, MD, and Anne Davidson, MBBS, have been awarded top honors by the American College of Rheumatology and the Association of Rheumatology Professionals.
Albert Einstein College of Medicine Receives $6.6M in NIH Grants to Lead New York Consortium for Kidney, Urological, and Hematological Research and Training
The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $6.6 million grant to lead a New York-based consortium of medical schools to train young scientists in kidney, urology, and hematology research.
FIU wins $19.4M NIH grant to fight health disparities
Florida International University researchers are at the forefront of ensuring the health and well-being of underserved communities don't slip through the cracks.
Albert Einstein College of Medicine Researchers Develop Promising New Cancer Therapy
Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumor cells.
Grant for High-Risk, High-Impact Brain Cancer Research Awarded to Ivy Center Investigator
Dr. An-Chi Tien, Pharmacodynamics Core Leader of the Ivy Brain Tumor Center, is a recipient of the American Brain Tumor Association’s Discovery Grant, a one-year, $50,000 award, supporting faculty and scientists who propose high-risk, high-impact research with the potential to change current diagnostic or treatment models for brain tumor care.
Feinstein Institutes’ Valentin Pavlov Elected President of the International Society for Autonomic Neuroscience
The International Society for Autonomic Neuroscience (ISAN) has elected The Feinstein Institutes for Medical Research's Valentin Pavlov, PhD, as president in recognition of his dedication and research of the brain and autonomic nervous system, particularly in the regulation of inflammation and metabolism.
Berkeley Lights Reports Third Quarter 2022 Financial Results
Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.
New Digital Tool Dramatically Reduces Blood Clot Risk During and Post-Hospital Care, Feinstein Institutes Study Shows
Every year, approximately 8 million Americans are susceptible to dangerous, often fatal blood clots when they are admitted to the hospital for a medical illness such as stroke or an infection like COVID-19.
Canada's first and largest-scale vision-loss study is underway at St. Joe's thanks to $750,000 grant from the Juravinski Research Institute
With a $750,000 boost in funding from the Juravinski Research Institute, researchers at the Regional Eye Institute at St. Joseph's Healthcare Hamilton are spearheading the country's most comprehensive study into the prevalence of age-related macular degeneration.
Feinstein Institutes Bioelectronic Medicine Researchers Target Specific Vagus Nerve Fibers for More Precise, Effective Stimulation
Electrically stimulating the vagus nerve has shown potential to treat inflammatory diseases, including rheumatoid arthritis, lupus and diabetes.
Saint Louis University Launches New Institute to Advance Neuroscience Research
On Wednesday, Nov. 2, Saint Louis University announced the launch of the Institute for Translational Neuroscience.
DaVita Clinical Research Showcases Chronic Kidney Disease and Rare Disease Network, Presents New Research Findings at Kidney Week 2022
DaVita Clinical Research will highlight its latest research during the American Society of Nephrology Kidney Week, being held in Orlando from November 2-6, 2022.
Nanopharmaceutics, Inc. Announces the End of Patient Recruitment for the NCI Sponsored Phase 3 Clinical Study in Advanced-Stage Cervical and Vaginal Cancers with Cisplatin During Radiation Therapy with and without Triapine®
Nanopharmaceutics, Inc., a clinical-stage pharmaceutical development company, announced completion of patient enrollment in the 450 patient Phase 3 clinical study sponsored by the NCI, part of the National Institutes of Health, and led by NCI funded network group, NRG Oncology, with participation of the NCI National Clinical Trials Network.